CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Endpoints News
Original article

Bristol Myers scraps $100M Orum-partnered cancer drug

Phase 1BMS-986497ORM-6151
Related Companies

Read the original article

Published by Endpoints News on September 17, 2026 7:19 PM

Read Original